Influenza

Moderna announced new mRNA vaccine candidates to combat prevalent viruses, and is even developing their first-ever bacterial vaccine for Lyme disease.

"Antibiotics can safely be withheld in most patients with viral respiratory infections,” these study authors wrote.

New research suggests the majority of people hospitalized with influenza also had a chronic illness.

Hong Kong confirmed a case of a man critically ill with avian influenza. On the other side of the world, Colorado is reporting its worst-ever avian flu outbreak among birds of prey.

RSV cases spiked to unprecedented levels this season. Why were these infections so frequent and severe? Why has vaccine development taken so long?

“This was a total surprise,” said study lead author John Tsang, PhD.

All regions are experiencing influenza-like illness levels above the baseline, the CDC said.

Pediatric populations are disproportionately affected by influenza. The first cell-based quadrivalent flu vaccine offers potential for greater vaccine effectiveness.

The CDC is urging all eligible persons to receive a flu shot, but a new survey shows fewer adults are planning to get the vaccine this season.

A new study found that patients hospitalized with COVID-19 are at significantly higher risk for venous thromboembolism in the ensuing 3 months than are patients hospitalized with influenza.

The FDA has approved Baloxavir Marboxil (Xofluza) for children 5 years and older to treat and prevent influenza.

The report showed the protective benefits varied somewhat by cardiovascular disease subtype.

With the impending start to the 2022-2023 influenza season just a few months away, here is some information on what is being studied for vaccines as well as recommendations and new testing.

Listen to our interview with Sanofi vaccine expert Dr. Christopher Rizzo about what this preferential recommendation means, and why high-dose flu vaccines are needed for older adults.

Data on hospitalizations of children during the pandemic highlighted the seriousness of MIS-C, particularly in children of color.

The company is utilizing this platform to address new COVID-19 variants, combination vaccines, and potentially prevent HIV.

A Colorado person tested positive for avian influenza. The patient worked closely with poultry, their only symptom was fatigue, and they have since recovered after a few days.

The investigational vaccine's findings from their phase 1/2 clinical trial were reported at the World Vaccine Congress.

George Loukatos, MD, shares clinical pearls for the management of the SARS-CoV-2 and influenza viruses.

Dr George Loukatos reviews available tests for the detection of the SARS-CoV-2 and influenza viruses and the benefits of using 1-swab nasal tests.

The investigational shots utilizing their mRNA technology platform are being studied in adults in the US.

Patients scheduled for primary care appointments were more likely to get an influenza vaccine if they received a text message the night before indicating one was reserved for them, a new study shows.

George Loukatos, MD, defines the term “flurona” and provides insight on common symptoms and targeting treatment from a respiratory standpoint for coinfection with SARS-CoV-2 and influenza.

Dr George Loukatos illuminates influenza vaccination rates and prevalence of influenza cases for the current flu season compared to previous years as well as the current status of COVID-19 in the US.

Findings of JAMA Network Open analysis reveal effects of interventions designed to prevent spread.